*Investors Blog*
- Thread starter Warstud
- Start date
He should start his own oil company
Zee09
$200 Site Donor 2023
- Joined
- May 5, 2018
- Messages
- 20,871
I already have some handy
Kcjeep said the green bottle was the bomb
He did, then sold it same day.
Zee09
$200 Site Donor 2023
- Joined
- May 5, 2018
- Messages
- 20,871
You sound like my buddy in TNHe did, then sold it same day.
Owen Lucas
$100 Site Donor 2023
- Joined
- Sep 5, 2021
- Messages
- 3,588
I wonder what kind of fight the pharma industry will put up here? What loopholes will they find?
From my understanding, the most favored nation order would set US drug prices at the lowest cost afforded to another country. In this case, does pharma back out of those markets or raise world prices?
Zee09
$200 Site Donor 2023
- Joined
- May 5, 2018
- Messages
- 20,871
I have the same questions
Big $$$ involved here
- Joined
- Jun 22, 2022
- Messages
- 1,545
A month
He should start his own oil filter company
Interesting day. Equities rallied as expected. 5% from all time highs. @Dave Hess may see his prediction fruition sooner than later.
Rates and dollar rising. Also to be expected. I wonder how far we rally if 10UST > 4.5%?
I would have expected to see Crypto rise also. Did not. Liquidity squeeze?
I think we can melt up from here barring a different headline or lack of liquidity. Glad I pushed in last week. Still have 30% cash though?
Rates and dollar rising. Also to be expected. I wonder how far we rally if 10UST > 4.5%?
I would have expected to see Crypto rise also. Did not. Liquidity squeeze?
I think we can melt up from here barring a different headline or lack of liquidity. Glad I pushed in last week. Still have 30% cash though?
The concept was put forth via EO in his first term which was challenged in court. It's also light on details, the summary I have seen highlights that HHS has 30 days to set a target price followed by 180 days for a company to negotiate with HHS before the agency imposes rules (yet to be determined) to implement MFN pricing. Not a lot of details on the in between, granted it is an executive order.
Some other tidbits I saw highlighted in the EO (though I have not seen much written on):
- facilitating direct-to-consumer purchasing programs for pharmaceutical manufacturers that sell their products to American patients at the most-favored-nation price.
- allowing for importation to procure drugs on a case-by-case basis from developed nations with low-cost prescription drugs.
Manufacturers are already standing up direct to consumer programs (with questions on those coming from government officials). Importation has fallen flat on it's face a number of times. And nothing addresses that unlike most of the rest of the world, the US market operates with brand name drugs sold at a list price and rebated back to health plans/PBMs for the vast majority of people (if you go get a prescription and don't have insurance, don't you at least ask for the GoodRx price?). The gross to net on brand name drugs is already ~50% off (on average) but is rarely factored in when US prices are discussed.
FWIW, XBI was up 4% today compared to 3.3% on the S&P. PBM and health plan stocks seemed to preform well below market today though from the handful I checked.
Im not tired of winning yet
I'll take it! The portfolio is up 32% on the 30 day.
I paid off my (monthly) credit card in full (always of course) and I'm still winning!
Owen Lucas
$100 Site Donor 2023
- Joined
- Sep 5, 2021
- Messages
- 3,588
This isn't promising if it failed the first round. The whole idea of price fixing, I don't know how constitutional that is and how much retaliation big pharma can take. If there ever was a cause to implement price caps, this would be it. Afterall, the pharmaceutical companies have agreed to these caps in other countries. I'd like to see their defense here.
I presume their will be more volatility in the pharma industry, maybe another dip that can be bought on the way down in case better news comes out? Pharma's influence runs deep, there a reason they are called the fifth pillar of the government, right after wall street which is the 4th lol.
It's killing me after getting trashed since Feb. I thought yesterday was good in post #6,970 and now getting near or at an 11% return for the year up 100% from this time yesterday.
I love META before the tariff thing I was up 40% in less than a year. Now I am at the 30% mark and feel like taking profits. Im just not sure how real the jubilation is about the tariff cut. Thing is I dont know what else I want to own. Other two holdings in this account are WMT and AMZN
I'll most likely procrastinate and hold.
I love META before the tariff thing I was up 40% in less than a year. Now I am at the 30% mark and feel like taking profits. Im just not sure how real the jubilation is about the tariff cut. Thing is I dont know what else I want to own. Other two holdings in this account are WMT and AMZN
I'll most likely procrastinate and hold.
Pharma companies often forego launching drugs in markets outside the US, launch them later than in the US or pull drugs from markets outside the US if they can't settle on prices. Markets outside of the US are typically single payer, where the government or an appointed entity is negotiating a price for all patients to access the drug, and guarantees that all patients have access.
The US isn't set up that way, PBMs and health plans negotiate different coverage for products. You may have access to a product that my health plan doesn't cover and vice versa. The net prices in the US are not transparent to you and I either, unless we pay the cash price for the first X thousand dollars of our spend, it's typically masked with copay/coinsurance. Somebody should ask, if most favored nation prices are going into effect, what will happen to rebates paid by manufacturers to PBMs and health plans? And then how will PBMs and health plans adjust based on the change in rebate revenue?
My guess is, if enacted, most favored nations pricing will be a credit to the government, revenue will shrink for PBMs and health plans and health plans will adjust consumer's premiums accordingly, effective passing the lost revenue as a price increase to the consumer.
Where are some of those folks????
Hot DAWG!!!
Hot DAWG!!!
Which will play directly into the hands of those wanting single payer. Which is fine by me FWIW.
These big companies play way too many games. I get a couple scripts - were $4 at walmart.
Doc changed one to "time release" so now it was $39 at walmart. OK I give them my insurance, so its now $12 at Walmart, but my one that used to be $4 is now also $12? Who got the extra $8? I have a guess.
2 weeks ago I would have told you to load up on Broadcom AVGO . Think Nivda has 20-30 more .
